Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Drugstore.com plots additional microsites

This article was originally published in The Tan Sheet

Executive Summary

The e-retailer will launch five to eight targeted microsites in 2010, including one potentially geared toward vitamins. All drugstore.com's microsites "will focus on attractive product categories with high margins," said CEO Dawn Lepore during an Oct. 20 third-quarter earnings call. The Bellevue, Wash., firm introduced 1www.sexualwellbeing.com in August and plans another microsite in 2009 (2"The Tan Sheet" Aug. 10, 2009). In the quarter ended Sept. 27, drugstore.com grew OTC net sales 16.5 percent to $71.3 million. Lepore highlighted vitamins and supplements, which grew 35 percent, and oral care, up 30 percent. Overall net sales jumped 10.2 percent to $96.8 million, though drugstore.com still reported a net loss of $1.6 million, compared to a net loss of $3.6 million in the year-ago quarter

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS103450

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel